GE HealthCare is facing challenges due to China's retaliatory tariffs and an anti-dumping probe, affecting its sales in China. Shares of GEHC, GE Vernova, and GE Aerospace dropped significantly, with GEHC hit the hardest due to the probe into medical CT tubes.